Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster

NCATS Open Data2024-10-08 更新2026-08-08 收录

新冠疫苗加强针免疫评估

抗体持久性

数据链接：

https://doi.org/10.1016/j.xcrm.2024.101701 数据链接链接失效反馈

官方服务：

资源简介：

Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster

创建时间：

2024-09-17

Persistence of antibody to 23-valent pneumococcal polysaccharide vaccine: a 5-year prospective follow-up cohort study

疫苗效果评估

抗体持久性

Pneumococcal vaccines are effective in preventing pneumococcal diseases in adults. The evaluation of the antibodies persistence to the 23-valent pneumococcal polysaccharide vaccine (PPV23) could provi

DataCite Commons2025-07-07 更新100

Supplementary Material for: Prolonged Treatment of Peanut-Allergic Mice with Bortezomib Significantly Reduces Serum Anti-Peanut IgE but Does Not Affect Allergic Symptoms

过敏免疫治疗

抗体持久性

Background: Anti-peanut immunoglobulin E (anti-Pn IgE) can persist throughout life, suggesting that this condition could be maintained by long-lived antibody-secreting cells (ASCs). To determine the r

NIAID Data Ecosystem40

Persistence of haemagglutination inhibition (HI) antibody responses to the A(H1N1)pdm09 influenza virus in the non-IIV revaccinated subjects.

抗体持久性

免疫效果评估

Persistence of haemagglutination inhibition (HI) antibody responses to the A(H1N1)pdm09 influenza virus in the non-IIV revaccinated subjects.

NIAID Data Ecosystem30

Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection

母婴免疫传递

抗体持久性

To evaluate the persistence of vaccine-induced maternal anti-S IgG in infant blood and compared persistence of infant anti-S IgG after maternal vaccination vs natural infection.

DataCite Commons2022-12-21 更新80

Table_2_Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer.DOCX

新冠疫苗加强针免疫评估

内分泌癌症患者疫苗应答

BackgroundOur study aimed to evaluate the safety and immunogenicity of the third (booster) dose of the COVID-19 vaccine for patients with endocrine-related cancers. MethodsThis observational study inv

NIAID Data Ecosystem40

Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster

资源简介：

相关数据集